Compare CE-Budesonide Nasal Solution & Rhinocort Aqua in an EEC Study of AR
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study was to compare the relative efficacy of Budesonide
administered via Captisol-Enabled Budesonide nasal solution and Rhinocort Aqua in patients
with seasonal allergic rhinitis (SAR) exposed to controlled ragweed pollen using an EEC
model.